Education
About Us
Working with TipRanks
Follow Us
Anthony Fiorino Insider Profile
4 Followers
Anthony Fiorino, CEO at Brainstorm Cell Therapeutics, holds 0.00 shares in Brainstorm Cell Therapeutics (Ticker: BCLI), holds 0.00 shares in Immune Pharmaceuticals (Ticker: IMNPQ), holds ― shares in Navidea (Ticker: NAVB). Most recently, Anthony Fiorino ― shares of Brainstorm Cell Therapeutics on ― for an estimated value of ―.
Anthony Fiorino Brainstorm Cell Therapeutics (BCLI)CEO
Brainstorm Cell Therapeutics (BCLI)
CEO
Ranked #62,079 out of 78,624 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-38.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Anthony Fiorino does not currently own shares as a corporate insider.
A breakdown of Anthony Fiorino's holdings
Insider Roles
Roles that Anthony Fiorino holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 23, 2018 - May 23, 2019
Return:-36.90%
The most profitable trade made by Anthony Fiorino
Anthony Fiorino's Trading History
Brainstorm Cell Therapeutics
―
CEO
―
$0.00
Navidea
Jun 30, 2017
Director
Uninformative Buy
―
―
Immune Pharmaceuticals
Feb 04, 2020
Director
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Anthony Fiorino's performance on stock
You May Also Like
Anthony Fiorino insider profile FAQ
What is the percentage of profitable transactions made by Anthony Fiorino?
The percentage of profitable transactions made by Anthony Fiorino is 0%.
What is the average return per transaction made by Anthony Fiorino?
The average return per transaction made by Anthony Fiorino is -38.60%.
What stocks does Anthony Fiorino hold?
Anthony Fiorino holds: BCLI, NAVB, IMNPQ stocks.
What was Anthony Fiorino’s latest transaction?
Anthony Fiorino latest transaction was an Uninformative Buy of ―.
What was Anthony Fiorino's most profitable transaction?
Anthony Fiorino’s most profitable transaction was an Informative Buy of IMNPQ stock on May 23, 2018. The return on the trade was -36.90%.
What is Anthony Fiorino's role in Brainstorm Cell Therapeutics?
Anthony Fiorino's role in Brainstorm Cell Therapeutics is CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.